Similar Papers

Paper Title
Journal
Date
Author
Abstract 4505: Anti-tumor activity in pancreatic cancer of a low immunogenic and clinically optimized anti-mesothelin immunotoxin RG7787
Ira Pastan ... Emily Mason-Osann
Cancer Research | VOL. 74
Ira Pastan, et. al.Ira Pastan ... Emily Mason-Osann
30 Sep 2014
202 In vitro and in vivo combination therapy of Low Molecular Weight Heparins, chemotherapy and immunotherapy, induce antitumor activity in Pancreatic Cancer
Adriana Papadimitropoulou ... Theodoros Liakakos
Journal for ImmunoTherapy of Cancer | VOL. 8
Adriana Papadimitropoulou, et. al.Adriana Papadimitropoulou ... Theodoros Liakakos
01 Nov 2020
Retraction: "Concurrent inhibition of NF-κB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer" by Ali et al.
-
Journal of cellular biochemistry | VOL. 117
--
15 Jun 2016
Data from Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer
Aik Choon Tan ... Akhilesh Pandey
-
Aik Choon Tan, et. al.Aik Choon Tan ... Akhilesh Pandey
31 Mar 2023
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Expanding the role of CDK4/6 inhibitors in early breast cancer: insights from the NATALEE trial
Marcela Carausu ... Michail Ignatiadis
Annals of Oncology | VOL. 36
Marcela Carausu, et. al.Marcela Carausu ... Michail Ignatiadis
01 Feb 2025
Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitors
J.M Riedl ... R.B Corcoran
Annals of Oncology | VOL. -
J.M Riedl, et. al.J.M Riedl ... R.B Corcoran
01 Feb 2025
Whole genome sequencing powered ctDNA sequencing for breast cancer detection
I Garcia-Murillas ... N.C Turner
Annals of Oncology | VOL. -
I Garcia-Murillas, et. al.I Garcia-Murillas ... N.C Turner
01 Feb 2025
Table of Contents
-
Annals of Oncology | VOL. 36
--
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.